ArticleDiagnostics (Basel, Switzerland)2023
Machine-Learning-Based Diabetes Mellitus Risk Prediction Using Multi-Layer Neural Network No-Prop Algorithm.
Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 25 citations in OpenAlex.
- An Effective Model-Based Voting Classifier for Diabetes Mellitus Classification.Bioengineering (Basel, Switzerland) · 2026Article
- Intelligent Bi-LSTM with Architecture Optimization for Heart Disease Prediction in WBAN through Optimal Channel Selection and Feature Selection.Biomedicines · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the past few decades, the prevalence of chronic illnesses in humans associated with high blood sugar has dramatically increased. Such a disease is referred to medically as diabetes mellitus. Diabetes mellitus can be categorized into three types, namely types 1, 2, and 3. When beta cells do not secrete enough insulin, type 1 diabetes develops. When beta cells create insulin, but the body is unable to use it, type 2 diabetes results. The last category is called gestational diabetes or type 3. This happens during the trimesters of pregnancy in women. Gestational diabetes, however, disappears automatically after childbirth or may continue to develop into type 2 diabetes. To improve their treatment strategies and facilitate healthcare, an automated information system to diagnose diabetes mellitus is required. In this context, this paper presents a novel system of classification of the three types of diabetes mellitus using a multi-layer neural network no-prop algorithm. The algorithm uses two major phases in the information system: the training phase and the testing phase. In each phase, the relevant attributes are identified using the attribute-selection process, and the neural network is trained individually in a multi-layer manner, starting with normal and type 1 diabetes, then normal and type 2 diabetes, and finally healthy and gestational diabetes. Classification is made more effective by the architecture of the multi-layer neural network. To provide experimental analysis and performances of diabetes diagnoses in terms of sensitivity, specificity, and accuracy, a confusion matrix is developed. The maximum specificity and sensitivity values of 0.95 and 0.97 are attained by this suggested multi-layer neural network. With an accuracy score of 97% for the categorization of diabetes mellitus, this proposed model outperforms other models, demonstrating that it is a workable and efficient approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.